- Home
- / AbClon
AbClon
Stock Price
₩15.9 K
2024-10-29
Market Capitalization
₩290.3 B
2024-10-29
Revenue
₩2.3 B
FY, 2024
AbClon Summary
Company Summary
- Overview
- AbClon (앱클론(주)) is a developer, manufacturer, and distributor of antibody drugs. It offers technology and therapeutic antibodies including pipeline products such as AC101, AC103, etc.
- Type
- Public
- Status
- Active
- Founded
- 2010
- HQ
- KR | view all locations
- Website
- http://www.abclon.co.kr
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Seoul HQ
Korea (Republic of)
1401, 285 Digital-ro, Guro-gu
AbClon Financials
Summary Financials
- Revenue (Q3, 2025)
- ₩1.6B
- Gross profit (Q3, 2025)
- ₩320.5M
- Net income (Q3, 2025)
- (₩3.5B)
- Cash (Q3, 2025)
- ₩11.5B
- EBIT (Q3, 2025)
- (₩3.6B)
- Enterprise value
- $286.0B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026